Clinical Social Workers in Belle Chasse, LA Accepting Medicare
5 Clinical Social Workers found. Showing 1 - 5
 Miss Karen Mcgillivray, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 103 E X St, Belle Chasse, LA 70037 Phone: 504-394-5309 Fax: 877-902-5562 |
Delphine Alexandra Naudin, LCSW-BACS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Keating Dr, Belle Chasse, LA 70037 Phone: 504-393-5750 Fax: 504-393-5760 |
 John J Trumbaturi Iii, LCSW, ACSW, C-SSWS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1484 Woodland Hwy, Belle Chasse, LA 70037 Phone: 504-595-6067 Fax: 504-398-0844 |
Ms. Joan Waelde Gossett, LCSW-BACS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3708 Main St, Belle Chasse, LA 70037 Phone: 504-393-5626 Fax: 504-393-5633 |
Trinh Nguyen Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 139 Badalamenti Ln, Belle Chasse, LA 70037 Phone: 504-912-3305 |
News Archive
CBO: Slowed federal health spending yields savings
Federal spending on health care has slowed sharply, partly as a result of the federal health care law, reports the Congressional Budget Office.
New research could help reverse side effects of acetaminophen overdose
New research could help reverse deadly side effects caused by excessive doses of the drug acetaminophen, the major ingredient in Tylenol and many other over-the-counter and prescription medicines.
New fluorescent dye technique may provide new insight into how cancerous tumors begin and grow
A technique developed by University of California, San Diego biologists, which uses bright fluorescent dyes to reveal the activity of genes in individual cells of an organism, promises to be a boon to developmental biologists, and may provide new insight into how cancerous tumors begin and grow.
Charity introduces new Hereditary Cancer Risk Tool to fight ovarian cancer
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
Vermillion receives USPTO patent for PAD biomarker
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
› Verified 2 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Psychologists
Occupational Therapists